INTRODUCTION
This compendium and the accompanying floppy diskettes are the result of an effort to compile and rapidly publish all relevant molecular data concerning the human immunodeficiency viruses (HIV) and related retroviruses. The scope of the compendium and database is best summarized by the five parts that it comprises: (I) Nucleic Acid Alignments and Sequences; (II) Amino Acid Alignments; (III) Analysis; (IV) Related Sequences; and (V) Database Communications. Information within all the parts is updated throughout the year on the Web site, http://hiv-web.lanl.gov.
While this publication could take the form of a review or sequence monograph, it is not so conceived. Instead, the literature from which the database is derived has simply been summarized and some elementary computational analyses have been performed upon the data. Interpretation and commentary have been avoided insofar as possible so that the reader can form his or her own judgments concerning the complex information. In addition to the general descriptions below of the parts of the compendium, the user should read the individual introductions for each part.
Part I. Nucleic Acid Alignments and Sequences. Annotated nucleic acid sequences of certain HIVs and SIVs are presented in a form close to that of the GenBank Sequence Library. Our few modifications of standard GenBank format were instituted to better serve the particular community for which this database is intended. Beginning in 1995, most sequences are not presented but rather are catalogued, in order to conserve space; the full formatted GenBank entries of these sequences are located on the Web site (http://hiv-web.lanl.gov) and the database FTP server.
The LOCUS name or identifier of an entry may differ slightly from that found in the GenBank or EMBL libraries, but the ACCESSION numbers are identical for entries in all (four) nucelotide sequence databases. Thus each entry is universally and uniquely traceable. Sequences may also be described by COMMON NAMES.The SOURCE line provides information, when available, about the infectivity or biological activity of the molecular clone from which a sequence has been derived. REFERENCES are limited to literature or personal communications having authority for the original sequence data; references that review sequence information, or that shed light upon the function or variation of coding and regulatory sequences, are listed in Part V.
Entries in Part I are annotated within the sequence, while their GenBank or EMBL-formatted versions on the floppy diskettes make use of FEATURES tables. The hard-copy annotation includes coding regions, regulatory structures, splice sites, and other features of functional significance. The authority for this annotation is largely invariance, the recurrence of patterns such as TATAA and AATAAA. Although our practice has been to conservatively annotate, we caution the user against docility: sequence information regarding transcripts, for example, is far from certain or complete at this time. Part I is sometimes divided into three subsections, A, B, and C, concerned with HIV-1s, HIV-2/SIVs, and SIVAGMs, SIVMND and SIVSYK.
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Part IV. Related Sequences. Heretofore, this section of the compendium has featured HIV related viral sequences-of nonprimate lentiviruses and the human T-cell lymphotropic viruses. Beginning in 1993, Part IV entries include, with greater emphasis, coding sequences for cellular proteins involved with HIV pathogenesis. In 1996, there are articles summarizing cellular factors and viral mimicry. Part V. Database Communications. This part contains a printed supplemental reference list for citations in 1995 and 1996. It also provides diskettes of sequences and information about accessing sequences through Internet. The floppy diskettes contain new nucleic acid sequences from Part I (especially those found in alignments) and Part IV and their translated amino acid sequences. For the most current information regarding database files, see the READ.ME file on each diskette. Nucleotide entries are presented in GenBank format for North American users and in EMBL format for European users (unless otherwise requested). Similarly, amino acid sequences are in either PIR or Swiss-Prot format. The diskettes themselves are either 3.5" IBM-DOS format or 3.5" Macintosh format, depending upon what has been requested. If there is any trouble using these files with software designed to work with the format we have sent, please let us know the name of the program you are using and the file that it could not handle.
A comprehensive compilation of the nucleic acid and protein sequences published in the Human Retroviruses and AIDS Database since 1987 is available through our Web site, http://hiv-web.lanl.gov and on our FTP Server, as described in Part V.
We are prepared to quickly enter both protein and nucleotide sequences into the Human Retroviruses and AIDS database, and in the case of nucleotide sequences, oversee their entry into the large gene libraries. Submission of unpublished sequences is invited and encouraged. Sequence data or inquiries regarding the database should be addressed to 
HIV-2

GENES AND GENE PRODUCTS
GAG genomic region encoding the capsid proteins (group specific antigens). The precursor is the p55 myristylated protein, which is processed to p17 (MAtrix), p24 (CApsid), p7 (NucleoCapsid), and p6 proteins, by the viral protease. Gag associates with the plasma membrane where the virus assembly takes place. The 55 kDa Gag precursor is called assemblin to indicate its role in viral assembly.
POL the genomic region encoding the viral enzymes protease, reverse transcriptase and integrase. These enzymes are produced as a Gag-pol precursor polyprotein, which is processed by the viral protease; the Gag-pol precursor is produced by ribosome frameshifting at the C-terminus of gag.
ENV viral glycoproteins produced as a precursor (gp160) and processed to the external glycoprotein gp120 and the transmembrane glycoprotein gp41. The mature proteins are held together by non-covalent interactions; as a result, a substantial amount of gp120 is released in the medium. gp120 contains the binding site for the CD4 receptor.
TAT Transactivator of HIV gene expression. One of the two necessary viral regulatory factors (Tat and Rev) for HIV gene expression. Two forms are known, Tat-1exon (minor form) of 72 amino acids and Tat-2exon (major form) of 86 amino acids. The electrophoretic mobility of these two forms in SDS gels is anomalous, with apparent sizes of approximately 16 kD and 14 kD for Tat-2exon and Tat-1exon, respectively. Low levels of both proteins are found in persistently infected cells. Tat has been localized primarily in the nucleolus/nucleus by immunofluorescence. It acts by binding to the TAR RNA element and activating transcription initiation and/or elongation from the LTR promoter. It is the first eukaryotic transcription factor known to interact with RNA rather than DNA and may have similarities with prokaryotic anti-termination factors. Extracellular Tat can be found and can be taken up by cells in culture.
REV The second necessary regulatory factor for HIV expression. A 19 kD phosphoprotein, localized primarily in the nucleolus/nucleus, Rev acts by binding to RRE and promoting the nuclear export, stabilization and utilization of the viral mRNAs containing RRE. Rev is considered the most functionally conserved regulatory protein of lentiviruses. Rev cycles rapidly between the nucleus and the cytoplasm.
VIF Viral infectivity factor, typically 23 kD. Promotes the infectivity but not the production of viral particles. In the absence of Vif the produced viral particles are defective, while the cell-to-cell transmission of virus is not affected significantly. Found in almost all lentiviruses, Vif is a cytoplasmic protein, existing in both a soluble cytosolic form and a membrane-associated form. The latter form of Vif is a peripheral membrane protein that is tightly associated with the cytoplasmic side of cellular membranes. Some recent observations suggest that Vif is incorporated in the virion. NEF (previously named 3 ORF) is an approximately 27-kd myristylated protein produced by an ORF located at the 3 end of the primate lentiviruses. Other forms of Nef are known, including nonmyristylated variants. Nef is predominantly cytoplasmic and associated with the plasma membrane via the myristyl residue linked to the conserved second amino acid (Gly). Nef has also been identified in the nucleus and found associated with the cytoskeleton in some experiments. Its association with the virion is suspected but not proven. One of the first HIV proteins to be produced in infected cells, it is the most immunogenic of the accessory proteins. Initially thought to be a negative factor, Nef was found to be important for viral replication in vivo. The nef genes of HIV and SIV are dispensable in vitro, but are essential for efficient viral spread and disease progression in vivo. Nef is necessary for the maintenance of high virus loads and for the development of AIDS in macaques. Nef downregulates CD4, the primary viral receptor, and is also proposed to increase viral infectivity. Nef contains PxxP motifs that bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of HIV but not for the downregulation of CD4.
VPR
VPX Virion protein of 12 kD found only in HIV-2/SIVagm and not in HIV-1 or SIVmnd. Vpx function in relation to Vpr is not fully elucidated. Vpx is necessary for efficient replication of SIV in PBMCs. Some studies indicate that Vpx and Vpr proteins may be functionally distinct. Progression to AIDS and death in SIV-infected animals can occur in the absence of Vpr or Vpx. Double mutant virus lacking both vpr and vpx was severely attenuated, whereas the single mutants were not, suggesting a redundancy in the function of Vpr and Vpx related to virus pathogenicity.
TEV (also named tnv) tripartite 28 kD viral phosphoprotein produced by some HIV-1 strains. Found primarily in the nucleolus/nucleus. Tev contains the first exon of Tat, a small part of Env and the second exon of Rev. It exhibits both Tat and Rev functions and can functionally replace both essential regulatory proteins of HIV-1. It is produced very early in infection.
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STRUCTURAL PROTEINS/VIRAL ENZYMES The products of gag, pol and env genes, which are essential components of the retroviral particle. ACCESSORY OR AUXILIARY PROTEINS additional virion and non-virion-associated proteins produced by HIV/SIV retroviruses: Vif, Vpr, Vpu, Vpx, Nef. Although the accessory proteins are in general not necessary for viral propagation in tissue culture, they have been conserved in the different isolates; this conservation and experimental observations suggest that their role in vivo is very important.
REGULATORY PROTEINS
COMPLEX RETROVIRUSES Retroviruses regulating their expression via viral factors and expressing additional proteins (regulatory and accessory) essential for their life cycle.
